Target intelligence / Profile preview

Kainate-type glutamate receptor subunit GRIK4 (GRIK4)

Target
GRIK4
Molecular classification
Ion channel, Receptor, Ligand-gated ion channel, Glutamate receptor
01

Overview

GRIK4 (Glutamate receptor, ionotropic, kainate 4) is a subunit of the kainate-type glutamate receptors, which are ligand-gated ion channels in the central nervous system. These receptors mediate excitatory neurotransmission by allowing cation flow upon binding glutamate, the major excitatory neurotransmitter in the brain. The protein itself cannot form functional channels alone; it must coassemble with other kainate receptor subunits (GluK1–GluK3) to create functional heteromeric channels. These assembled receptors are permeable to cations and play a key role in synaptic transmission and plasticity. Variants or altered expression of GRIK4 have been linked to several neuropsychiatric conditions, including depression, bipolar disorder, schizophrenia, autism spectrum disorders, and intellectual disability.

Other names
GRIKKA1
02

Mechanism of action

Cation-permeable ligand-gated ion channel

03

Biological functions

Synaptic transmissionSynaptic plasticityNeural circuit maturationExcitatory neurotransmission
04

Disease associations

DepressionBipolar disorderSchizophreniaAutism spectrum disordersIntellectual disabilityMental retardationAnxiety disorders

Beyond the preview

Go deeper on Kainate-type glutamate receptor subunit GRIK4 (GRIK4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kainate-type glutamate receptor subunit GRIK4 (GRIK4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call